Made available in DSpace on 2014-12-17T14:13:20Z (GMT). No. of bitstreams: 1
CarlosANJ.pdf: 292862 bytes, checksum: 36f729a3d08d7c1e5c99393f43d9acef (MD5)
Previous issue date: 2007-10-19 / Tamoxifen (TX), a drug used in the treatment of breast cancer, may cause hepatic changes in some patients. The consequences of its use on the liver tissues of rats with or without diabetes mellitus (DM) have not been fully explored. The purpose of this multidisciplinary study was to evaluate the
correlation between plasma hepatic enzyme levels and the presence of iron overload in the hepatic tissue of female Wistar rats with or without streptozotocin-induced DM and using TX. Female rats were studied in control groups: C-0 (non-drug users), C-V (sorbitol vehicle only) and C-TX (using TX). DM (diabetic non-drug users) and DM-TX (diabetics using TX) were the test groups. Sixty days after induced DM, blood samples were collected for glucose, alanine aminotransferase (ALT), aspartate aminotransferase (AST) alkaline phosphatase (ALP) and bilirubin measures. Hepatic fragments were processed and stained with hematoxylin and eosin (H&E), Masson s trichrome, Perls. The hepatic iron content was quantified by atomic absorption spectrometry. AST, ALT and ALP levels were significantly elevated in the DM and DM-TX groups, with unchanged bilirubin levels. Liver iron overload using Perls stain and atomic absorption spectrometry were observed exclusively in groups C-TX and DM-TX. There was positive correlation between AST, ALT and ALP levels and microscopic hepatic siderosis intensity in group DM-TX. In conclusion, TX administration is associated with liver siderosis in diabetic and non-diabetic rats. In addition, TX induced liver iron overload with unaltered hepatic function in
2 non-diabetic rats and may be a useful tool for investigating the biological control of iron metabolism / O tamoxifeno? (TX), utilizado no tratamento do c?ncer de mama, pode causar altera??es hep?ticas. As conseq??ncias de seu uso em tecido hep?tico de ratos com ou sem diabetes mellitus (DM) n?o foram completamente investigadas. O estudo de car?ter multidisciplinar visou avaliar a correla??o entre n?veis de enzimas hep?ticas no plasma e a presen?a de sobrecarga de ferro em tecido hep?tico de ratas com ou sem DM induzido por estreptozotocina e em uso de TX. Ratas Wistar foram estudadas em grupos? controle: C-O (sem uso de droga), C-V (somente sorbitol) e C-TX (em uso de TX). DM (diab?ticos sem uso de droga) e DM-TX (diab?ticos em uso de TX) foram os grupos teste. Sessenta dias ap?s a indu??o do DM, amostras de sangue foram colhidas para a mensura??o de glicose, alanina aminotransferase (ALT), aspartato aminotransferase (AST) , fosfatase alcalina (ALP) e bilirrubina. Amostras hep?ticas foram coradas com hematoxilina e eosina, Tricr?mio de Masson e Perls. O conte?do hep?tico de ferro foi quantificado por espectrometria de absor??o at?mica. AST, ALT e ALP apresentaram-se significativamente elevados nos grupos DM e DM-TX, com bilirrubina n?o alterada. Siderose ? colora??o Perls e pela espectrometria de absor??o at?mica foram observados apenas nos grupos C-TX e DM-TX. Houve correla??o positiva entre os n?veis de AST, ALT e ALP e a intensidade da siderose hep?tica microsc?pica no grupo DM-TX. Em conclus?o, o uso de TX ? associada com siderose hep?tica em ratas diab?ticas ou n?o. O TX induziu sobrecarga hep?tica de ferro sem alterar a fun??o hep?tica em animais n?o diab?ticos e pode ser uma ferramenta ?til no estudo do metabolismo do ferro.A participa??o de pesquisadores em Patologia, Cirurgia Experimental, Farm?cia Cl?nica, Toxicologia, Nutri??o, Mastologia, Endocrinologia e Biologia Molecular do Centro de Ci?ncias da Sa?de (CCS) e o Departamento de Estat?stica do Centro de Ci?ncias Exatas e da Terra (CCET), de forma integrada e coordenada, foi fundamental para a execu??o do projeto proposto, de car?ter multidisciplinar
| Identifer | oai:union.ndltd.org:IBICT/oai:repositorio.ufrn.br:123456789/13111 |
| Date | 19 October 2007 |
| Creators | Jatob?, Carlos Andr? Nunes |
| Contributors | CPF:04045599487, http://lattes.cnpq.br/2365612055067945, Juc?, Norma Thom?, CPF:16857640459, http://lattes.cnpq.br/8130614546005007, Marchini, J?lio S?rgio, CPF:88921115820, http://lattes.cnpq.br/2038597037372097, Ara?jo, Ana Cristina Pinheiro Fernandes de, CPF:70410798487, http://lattes.cnpq.br/7207146627442417, Melo, ?urea Nogueira de, CPF:07428219434, http://lattes.cnpq.br/7050175669166436, Ramos, Ana Maria de Oliveira |
| Publisher | Universidade Federal do Rio Grande do Norte, Programa de P?s-Gradua??o em Ci?ncias da Sa?de, UFRN, BR, Ci?ncias da Sa?de |
| Source Sets | IBICT Brazilian ETDs |
| Language | Portuguese |
| Detected Language | English |
| Type | info:eu-repo/semantics/publishedVersion, info:eu-repo/semantics/doctoralThesis |
| Format | application/pdf |
| Source | reponame:Repositório Institucional da UFRN, instname:Universidade Federal do Rio Grande do Norte, instacron:UFRN |
| Rights | info:eu-repo/semantics/openAccess |
Page generated in 0.0071 seconds